New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)

NCT00035269 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia, Pneumococcal
Community Acquired Infections
Gram-positive Bacterial Infections

Interventions

DRUG: Antibiotic

Sponsor

Pfizer